SCHEMBL4264138

SCHEMBL4264138

C=CC1=CC=COC1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3464312 0.70
SCHEMBL958693 0.70
SCHEMBL6348761 0.69
SCHEMBL7514573 0.65
SCHEMBL3463247 0.65
SCHEMBL3826416 0.65
SCHEMBL3464092 0.65
SCHEMBL4907605 0.65
SCHEMBL11601366 0.64
SCHEMBL9622191 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016068436-A1 CATHODE ACTIVE MATERIAL FOR LITHIUM SECONDARY BATTERY, PREPARATION METHOD THEREFOR AND LITHIUM SECONDARY BATTERY COMPRISING SAME 울산과학기술원 2016-05-06 WO claimed
EP-1542659-A4 PROCESS FOR COATING A PHARMACEUTICAL PARTICLE DU PONT (US) 2008-03-26 EP claimed
US-20050220996-A1 Process for coating a pharmaceutical particle E. I. DU PONT DE NEMOURS AND COMPANY 2005-10-06 US claimed
EP-1542659-A1 PROCESS FOR COATING A PHARMACEUTICAL PARTICLE E.I. DU PONT DE NEMOURS AND COMPANY (US) 2005-06-22 EP claimed
WO-2004016247-A1 PROCESS FOR COATING A PHARMACEUTICAL PARTICLE E.I. DU PONT DE NEMOURS AND COMPANY (US) 2004-02-26 WO claimed
WO-2016068436-A1 CATHODE ACTIVE MATERIAL FOR LITHIUM SECONDARY BATTERY, PREPARATION METHOD THEREFOR AND LITHIUM SECONDARY BATTERY COMPRISING SAME 울산과학기술원 2016-05-06 WO disclosed
WO-2009094394-A1 MICRONEEDLE DEVICES AND METHODS OF DRUG DELIVERY OR FLUID WITHDRAWAL GEORGIA TECH RESEARCH CORPORATION (US) 2009-07-30 WO disclosed
US-20090182306-A1 Microneedle Devices and Methods of Drug Delivery or Fluid Withdrawal GEORGIA TECH RESEARCH CORPORATION (US) 2009-07-16 US disclosed
EP-2034023-A1 C-C CKR-5 ,CC-Chemikines receptor, derivatives thereof and their uses Euroscreen S.A. (BE) 2009-03-11 EP disclosed
EP-1670611-A2 ELONGATED MEDICAL DEVICE FOR INTRACORPORAL USE Boston Scientific Limited (BB) 2006-06-21 EP disclosed
WO-2005035226-A2 ELONGATED MEDICAL DEVICE FOR INTRACORPORAL USE BOSTON SCIENTIFIC LIMITED (BB) 2005-04-21 WO disclosed
EP-0969007-B1 Method of making an aromatic chlorosilane compound by a hydrosilation reaction DOW CORNING ASIA LTD (JP) 2004-09-22 EP disclosed
US-6054602-A Method of making an aromatic chlorosilane compound by a hydrosilation reaction DOW CORNING ASIA, LTD. (JP) 2000-04-25 US disclosed
EP-0969007-A2 Method of making an aromatic chlorosilane compound by a hydrosilation reaction Dow Corning Asia, Ltd. (JP) 2000-01-05 EP disclosed
EP-0854718-A2 NOVEL COMPOSITION CONTAINING AN ACID-LABILE BENZIMIDAZOLE AND PROCESS FOR ITS PREPARATION Pharma Pass LLC (US) 1998-07-29 EP disclosed
WO-1997012580-A2 NOVEL COMPOSITION CONTAINING AN ACID-LABILE BENZIMIDAZOLE AND PROCESS FOR ITS PREPARATION PHARMA PASS LLC (US) 1997-04-10 WO disclosed
US-5359053-A Nucleic acid probes having nucleoside residue; usable with stringent hybridization conditions G. D. SEARLE & CO. (US) 1994-10-25 US disclosed
US-5134066-A Hybridization MONSANTO COMPANY (US) 1992-07-28 US disclosed
EP-0465744-A1 Formulations for sustained release dressings and their use Dow Corning France S.A. (FR) 1992-01-15 EP disclosed
EP-0415901-A2 Improved nucleic acid probes MONSANTO COMPANY (US) 1991-03-06 EP disclosed